Moreover, several studies have shown that treatment with TSP1 antagonist peptides can prevent bleomycin-induced lung fibrosis in mice and reduce the activation of TGF-β (Yehualaeshet et al., 2000; Chen et al., 2009; Ezzie et al., 2011). This evidence concerns the gene TGFB1 and pulmonary fibrosis.